Most of us are virtual meeting pros by now—and though many miss the connection and energy of in-person events, there is something to be said for attending sessions in sweatpants, a favorite coffee mug in hand
Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
Up to eight young investigators will present their work at the annual Young Investigator Symposium, taking place during the Virtual Fall 2020 Group Meeting
Mike Thompson writes that educating and engaging the public--both via social media and in person--is necessary to sustain a national clinical trials infrastructure and continue advancing cancer research